Log in

NASDAQ:SYRSSyros Pharmaceuticals Earnings Date, Estimates & History

$9.79
+0.28 (+2.94 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$9.23
Now: $9.79
$9.81
50-Day Range
$7.10
MA: $8.85
$10.18
52-Week Range
$4.26
Now: $9.79
$11.93
Volume258,650 shs
Average Volume356,297 shs
Market Capitalization$447.31 million
P/E RatioN/A
Dividend YieldN/A
Beta1.59

Earnings

Syros Pharmaceuticals (NASDAQ:SYRS) Earnings Information

Syros Pharmaceuticals last released its earnings data on May 7th, 2020. The reported ($0.39) EPS for the quarter, beating the consensus estimate of ($0.45) by $0.06. The business had revenue of $2.38 million for the quarter, compared to analysts' expectations of $1.72 million. Syros Pharmaceuticals has generated ($1.88) earnings per share over the last year. Syros Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 6th, 2020 based off prior year's report dates.

Syros Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Syros Pharmaceuticals (NASDAQ:SYRS) Earnings Estimates

2020 EPS Consensus Estimate: ($1.76)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203($0.47)($0.39)($0.44)
Q2 20203($0.49)($0.40)($0.44)
Q3 20203($0.50)($0.41)($0.45)
Q4 20203($0.52)($0.37)($0.44)
Q1 20211($0.53)($0.53)($0.53)
Q2 20211($0.57)($0.57)($0.57)
Q3 20211($0.58)($0.58)($0.58)

Syros Pharmaceuticals (NASDAQ SYRS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/6/2020
(Estimated)
       
5/7/20203/31/2020($0.45)($0.39)($0.39)$1.72 million$2.38 millionTranscript
3/5/202012/31/2019($0.47)($0.46)($0.46)$0.79 million$0.51 millionTranscript
11/12/2019Q3($0.48)($0.47)($0.47)$0.43 million$0.56 millionTranscript
8/1/2019Q2 2019($0.41)($0.47)($0.47)$0.42 million$0.46 millionTranscript
5/1/20193/31/2019($0.57)($0.49)($0.49)$0.42 million$0.45 millionN/A
3/7/201912/31/2018($0.49)($0.54)($0.54)$0.40 million$0.89 millionN/A
11/1/20189/30/2018($0.45)($0.47)($0.47)$0.72 million$0.41 millionTranscript
8/10/2018Q2 2018($0.50)($0.43)($0.43)$1.33 million$0.38 millionN/A
5/10/2018Q1 2018($0.34)($0.48)($0.48)$3.41 million$0.37 millionN/A
3/12/2018Q4 2017($0.57)($0.58)($0.58)N/A
11/8/2017Q3 2017($0.53)($0.53)($0.53)N/A
8/9/2017Q2 2017($0.55)($0.52)($0.52)N/A
5/15/2017Q1 2017($0.5920)($0.49)($0.49)$1.10 millionN/A
3/20/2017Q4 2016($0.66)($0.47)($0.47)$0.32 millionN/A
11/14/2016Q3 2016($0.56)($0.65)($0.65)N/A
8/15/2016Q2 2016($0.56)($5.42)($5.42)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.